Retrospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1125-1137
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1125
Preoperative albumin-bilirubin score is a prognostic factor for gastric cancer patients after curative gastrectomy
Daniel Jose Szor, Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Francisco Tustumi, Andre Roncon Dias, Bruno Zilberstein, Ulysses Ribeiro Jr
Daniel Jose Szor, Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Francisco Tustumi, Andre Roncon Dias, Bruno Zilberstein, Ulysses Ribeiro Jr, Department of Gastroenterology, Instituto do Cancer, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 01246000, Brazil
Author contributions: Szor DJ contributed to study design, data retrieval, statistical analysis, critical analysis, and draft of the manuscript; Pereira MA contributed to data retrieval, statistical analysis, critical analysis, and draft of the manuscript; Ramos MFKP, Tustumi F, and Dias AR contributed to data retrieval, critical analysis, and review of the manuscript; Zilberstein B contributed to critical analysis and review of the manuscript; Ribeiro Jr U contributed to implementation of the research, critical analysis, and review of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Hospital Ethics Committee and Registered Online https://plataformabrasil.saude.gov.br (approval No. 50971821.8.0000.0068).
Informed consent statement: Informed consent was waived by the local ethics committee given the retrospective nature of the study.
Conflict-of-interest statement: The authors declare no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Daniel Jose Szor, MS, PhD, Postdoc, Professor, Surgeon, Surgical Oncologist, Department of Gastroenterology, Instituto do Cancer, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, 251 Av Dr Arnaldo, Sao Paulo 01246000, Brazil. danszor@gmail.com
Received: January 10, 2023
Peer-review started: January 10, 2023
First decision: February 20, 2023
Revised: February 21, 2023
Accepted: April 17, 2023
Article in press: April 17, 2023
Published online: June 27, 2023
Processing time: 156 Days and 8 Hours
Core Tip

Core Tip: The present study evaluates the clinical impact of the preoperative albumin-bilirubin (ALBI) score in patients with gastric cancer who received curative treatment. We found that ALBI score is able to predict short-term and long-term outcomes of patients, and can be applied as a prognostic factor for gastric cancer. The ALBI is a simple and reproducible parameter that allows the risk stratification of patients within the pathologic stage stages, and may be an additional useful tool for decision-making regarding treatment and follow-up individualization.